Recognising the incredible women in the bladder cancer community - World Bladder Cancer Patient Coalition

Recognising the incredible women in the bladder cancer community - World Bladder Cancer Patient Coalition

On the occasion of International Women’s Day, the World Bladder Cancer Patient Coalition highlights the impact of bladder cancer on women and celebrates women patient advocates...

Defining cisplatin eligibility in patients with muscle-invasive bladder cancer - PubMed

Defining cisplatin eligibility in patients with muscle-invasive bladder cancer - PubMed

doi: 10.1038/s41585-020-00404-6. Online ahead of print. Defining cisplatin eligibility in patients with muscle-invasive bladder cancer Expand Affiliations 1 Division of Medical...

Identification of low-frequency variants of UGT1A3 associated with bladder cancer risk by next-generation sequencing

Identification of low-frequency variants of UGT1A3 associated with bladder cancer risk by next-generation sequencing

Identification of low-frequency variants of UGT1A3 associated with bladder cancer risk by next-generation sequencing Sequencing Abstract Although genome-wide association studies...

Bacterial strains augment cancer therapeutics

Bacterial strains augment cancer therapeutics

Evidence has accumulated to show that the composition of the gut microbiota affects cancer risk, disease progression and response to treatment. Indeed, the presence of...

Plasma ctDNA is a tumor tissue surrogate and enables clinical-genomic stratification of metastatic bladder cancer

Plasma ctDNA is a tumor tissue surrogate and enables clinical-genomic stratification of metastatic bladder cancer

Plasma ctDNA is a tumor tissue surrogate and enables clinical-genomic stratification of metastatic bladder cancer Nature Communications volume 12, Article number: 184 (2021)...

Recurring Urinary Tract Infections May Play A Role In Bladder Cancer

Recurring Urinary Tract Infections May Play A Role In Bladder Cancer

Researchers have known that the presence of E.coli bacteria is responsible for the most common outpatient infections —urinary tract infections (UTIs) —that have a lifetime...

ESU-ESOU virtual Masterclass on Non-Muscle-Invasive Bladder Cancer - ESU Masterclasses

ESU-ESOU virtual Masterclass on Non-Muscle-Invasive Bladder Cancer - ESU Masterclasses

Dr. Rik de Jongh (NL) “It was a very good masterclass. I wanted to learn more about en-bloc resection of bladder tumours and the various techniques such as incision electrode,...

Subtype specific expression and survival prediction of pivotal lncRNAs in muscle invasive bladder cancer

Subtype specific expression and survival prediction of pivotal lncRNAs in muscle invasive bladder cancer

Subtype specific expression and survival prediction of pivotal lncRNAs in muscle invasive bladder cancer Scientific Reports volume 10, Article number: 20472 (2020) Cite this...

Attention to detail and a permissive set-up: crucial for an effective TURBT

Attention to detail and a permissive set-up: crucial for an effective TURBT

The aspiration of surgeons performing transurethral resection of bladder tumour (TURBT) is the conflation of bladder preservation along with the objective triad of cancer...

New Standard in High-Risk Muscle-Invasive Bladder Cancer?

New Standard in High-Risk Muscle-Invasive Bladder Cancer?

Anti-PD-1 immunotherapy after radical surgery in high-risk muscle-invasive urothelial cancer improved disease-free survival (DFS), regardless of PD-L1 status, a randomized phase...

Quality of Life After Bladder Cancer: A Cross-sectional Survey of Patient-reported Outcomes.

Quality of Life After Bladder Cancer: A Cross-sectional Survey of Patient-reported Outcomes.

Little is known about health-related quality of life (HRQOL) following treatment for bladder cancer (BC). To determine this, we undertook a cross-sectional survey covering 10%...

ASCO GU 2021: Radical Cystectomy for High-Risk Non-Muscle-Invasive Bladder Cancer: Who and Why?

ASCO GU 2021: Radical Cystectomy for High-Risk Non-Muscle-Invasive Bladder Cancer: Who and Why?

Data from Moschini and colleagues suggest that whether T2 disease is de novo or progressive is prognostically important. Among 768 patients undergoing radical cystectomy at a...